Schuijs et al. have documented that IL-5, derived from ILC2s, stimulates eosinophils and subsequently suppresses Th1-mediated anti-tumor immunity, which ultimately promotes lung cancer metastasis and escalates mortality rates [29]. The gene discussed is IL5; the disease is lung carcinoma.